129 Xenon MRI in Chronic Lung Disease

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Lung Disease
Interventions
DEVICE

Hyperpolarized Xenon MRI

Hyperpolarized noble gas imaging using Xenon-129 has been used to explore structural and functional relationships in the lung in patients with lung disease and healthy controls. In contrast to proton-based MRI imaging, 129Xe gas is used as a contrast agent to directly visualize the airways, and thus ventilation. Whereas the normal density of gas is too low to produce an easily detectable signal, this is overcome by artificially increasing the amount of polarization per unit volume using optical pumping.

Trial Locations (1)

N6A 5B7

RECRUITING

Robarts Research Institute; The University of Western Ontario; London Health Sciences Centre, London

All Listed Sponsors
lead

Western University, Canada

OTHER

NCT02723500 - 129 Xenon MRI in Chronic Lung Disease | Biotech Hunter | Biotech Hunter